3 ·Filed Jun 29, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
No actionable trading signal from this filing. Monitor for future Form 4 filings if the insider acquires shares, which could indicate alignment or conviction.
Final — all horizons settled through T+60d
CLDI ▼ -55.88% at T+60d
NEUTRAL call -55.88% · α vs SPY -58.62% · entry $0.1700 → $0.0750
T+1d
-7.06%
call -7.06% · α -6.92%
$0.1580
settled 4mo ago
T+5d
-16.41%
call -16.41% · α -16.23%
$0.1421
settled 4mo ago
T+20d
-45.12%
call -45.12% · α -42.80%
$0.0933
settled 3mo ago
T+60d
-55.88%
call -55.88% · α -58.62%
$0.0750
settled 5w ago
Price Chart
Loading chart...
Executive Summary
Corazon (Corsee) D. Sanders filed a Form 3 initial statement of beneficial ownership with Calidi Biotherapeutics, reporting zero shares held. This is a routine administrative filing for a new insider with no current equity stake, carrying no trading signal.
Key Facts
- New insider Corazon (Corsee) D. Sanders filed Form 3 on 2026-06-29, reporting zero beneficial ownership.
- A limited power of attorney was granted to executive officer Andrew Jackson to handle future Section 16 filings.
- No shares, options, or derivative securities were reported as beneficially owned.
Financial Impact
No financial impact — zero beneficial ownership reported.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (7 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001493152-26-031118 |
| Document: 0001493152-26-031118-index-headers.html | 0001493152-26-031118 |
| Document: 0001493152-26-031118-index.html | 0001493152-26-031118 |
| Document: 0001493152-26-031118.txt | 0001493152-26-031118 |
12 reports for CLDI
80% Hit rate @ T+20 Went positive at some point 5 of 6 best @ T+60▲ +53.89%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 8-K | $1.07 | awaiting T+20 | — | $0.6450 (+39.72%) |
Sep 22, 2026 4w ago | 8-K | $1.09 $0.7680 | ▲ +29.54% | ▲ +30.23% | $0.6450 (+40.83%) |
Sep 17, 2026 5w ago | 424B5 | $1.10 $0.8370 | ▲ +23.91% | ▲ +24.11% | $0.6450 (+41.36%) |
Aug 13, 2026 10w ago | 8-K | $1.59 $1.22 | ▼ −23.27% | ▼ −21.28% | $0.6450 (−59.43%) |
Aug 13, 2026 10w ago | Press Release | $1.59 $1.22 | ▼ −23.27% | ▼ −21.28% | $0.6450 (−59.43%) |
Jun 29, 2026 16w ago | 3 | $0.1700 $0.0933 | ▼ −45.12% | ▼ −42.80% | $0.6450 (+279.41%) |
May 26, 2026 21w ago | Press Release | $2.83 $2.51 | ▼ −11.30% | ▼ −9.24% | $0.6450 (−77.22%) |
May 22, 2026 22w ago | Press Release | $2.83 $2.51 | ▲ +11.30% | ▲ +9.24% | $0.6450 (+77.22%) |
Apr 20, 2026 27w ago | Press Release | $0.2500 $0.1830 | ▼ −26.80% | ▼ −31.00% | $0.6450 (+158.00%) |
Mar 27, 2026 30w ago | Press Release | $0.2390 $0.2240 | ▼ −6.28% | ▼ −18.87% | $0.6450 (+169.87%) |
Showing 10 of 12
US Market Status
Market Closed — Opens in 21m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers